The story of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical landscape . Although its early success and creation of countless in revenue , the intellectual property expiration has opened the floodgates for alternative medications, significantly eroding income prospects . This shif